-
301por Díaz‐Casas, Sandra Esperanza, Castilla‐Tarra, Jorge Alberto, Pena‐Torres, Esperanza, Orozco‐Ospino, Martha, Mendoza‐Diaz, Sara, Nuñez‐Lemus, Marcela, Garcia‐Angulo, Oscar, Garcia‐Mora, Mauricio, Guzman‐AbiSaab, Luis, Lehmann‐Mosquera, Carlos, Angel‐Aristizabal, Javier, Duarte‐Torres, Carlos, Vergel‐Martinez, Juan Carlos“…The aim of this study was to describe the pathological response obtained with neoadjuvant chemotherapy (NACT) according to the molecular classification of breast cancer in patients with locally advanced tumors treated within the National Cancer Institute (NCI) Functional Breast Cancer Unit (FBCU) in Bogotá, Colombia. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
302“…Data from the National Cancer Institute/National Toxicology Program (NCI/NTP) carcinogenesis bioassays were examined to compare cancer risks in rats and mice. …”
Enlace del recurso
Enlace del recurso
Texto -
303por Shelby, Michael D.“…EMIC is now sponsored by the National Institute of Environmental Health Sciences and the National Cancer Institute. From a simple registry of chemicals tested for mutagenicity, the scope and activities of EMIC have increased greatly. …”
Publicado 1978
Enlace del recurso
Enlace del recurso
Texto -
304“…This paper recalls the growth and development of the registry and the role played by the Connecticut legislature, the State Medical Society, the Connecticut Department of Health, and the National Cancer Institute in this process. For half a century, the registry has provided assistance to practitioners, hospitals, and research scientists, not only in Connecticut but across the country and around the world. …”
Enlace del recurso
Enlace del recurso
Texto -
305por Sy-Cordero, Arlene A., Graf, Tyler N., Wani, Mansukh C., Kroll, David J., Pearce, Cedric J., Oberlies, Nicholas H.“…These compounds were evaluated clinically by the U.S. National Cancer Institute in the 1970's and 1980's. However, they have yet to be advanced into viable drugs due to severe side effects. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
306por Perfetti, Vittorio, Ricotti, Mattia, Buonaguro, Franco, Tirelli, Umberto, Pedrazzoli, Paolo“…This is a report on some of the research activities currently ongoing in Italy as outlined at the “Viruses and solid tumors” meeting jointly organized by the Oncology Sections of IRCCS Policlinico “San Matteo” (Pavia) and IRCCS National Cancer Institute (Aviano), held in Pavia, Italy, on October 2011. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
307por Followill, David S., Urie, Marcia, Galvin, James M., Ulin, Kenneth, Xiao, Ying, FitzGerald, Thomas J.“…The National Cancer Institute (NCI) clinical cooperative groups have been instrumental over the past 50 years in developing clinical trials and evidence-based clinical trial processes for improvements in patient care. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
308“…METHODS: Using data from the United States National Cancer Institute Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, we examined the association between aspirin and ibuprofen use and HNC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
309“…This review covers chemical carcinogenesis studies in nonhuman primates performed by the National Cancer Institute, USA, to provide hitherto unavailable information on their susceptibility to compounds producing carcinogenic effects in rodents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
310por Ahsan, Mohamed Jawed, Khalilullah, Habibullah, Yasmin, Sabina, Jadav, Surender Singh, Govindasamy, Jeyabalan“…The anticancer effects were evaluated on a panel of 60 cell lines, according to the National Cancer Institute (NCI) screening protocol. There were 10 tested compounds among 14 synthesized compounds, which showed potent anticancer activity in both one-dose and 5-dose assays. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
311por Sanchez, Michael, Purcell, E. Peyton, Michie, Joan S., Tsakraklides, Sophia P., La Porta, Madeline, Vinson, Cynthia“…In 2011, the National Cancer Institute launched the Research to Reality (R2R) Pilot Mentorship Program to enhance mentees’ core evidence-based public health (EBPH) competencies. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
312por McShane, Lisa M., Cavenagh, Margaret M., Lively, Tracy G., Eberhard, David A., Bigbee, William L., Williams, P. Mickey, Mesirov, Jill P., Polley, Mei-Yin C., Kim, Kelly Y., Tricoli, James V., Taylor, Jeremy M. G., Shuman, Deborah J., Simon, Richard M., Doroshow, James H., Conley, Barbara A.“…The US National Cancer Institute (NCI), in collaboration with scientists representing multiple areas of expertise relevant to ‘omics’-based test development, has developed a checklist of criteria that can be used to determine the readiness of omics-based tests for guiding patient care in clinical trials. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
313por Hudson, Cody L., Topaloglu, Umit, Bian, Jiang, Hogan, William, Kieber-Emmons, Thomas“…This work presents two tools for improving data quality of clinical research data relying on the National Cancer Institute’s Common Data Elements as a standard representation of possible questions and data elements to A: automatically suggest CDE annotations for already collected data based on semantic and syntactic analysis utilizing the Unified Medical Language System (UMLS) Terminology Services’ Metathesaurus and B: annotate and constrain new clinical research questions though a simple-to-use “CDE Browser.” …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
314“…By understanding the differences in the drug efficacy and resistance at the level of protein–protein networks, we identified the correlation between the drug activity of oxaliplatin/5-FU and gene variations from the US National Cancer Institute-60 human cancer cell lines. The activity of either of these drugs is correlated with specific amino acid variant(s) of KRAS and other genes from the signaling pathways of colon cancer progression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
315“…Twenty-four compounds were screened biologically against two human tumor cell lines, breast carcinoma MCF-7 and hepatocellular carcinoma HePG-2, at the national cancer institute, Cairo, Egypt using 5-fluorouracil as standard drug. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
316“…The symposium highlighted recent progress from the National Cancer Institute's Provocative Questions Initiative, a program that offers research support to scientists who propose innovative strategies to address one of the featured questions. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
317“…All the synthesized derivatives were selected by National Cancer Institute (NCI), Bethesda, and evaluated for their in vitro anticancer activity in the full NCI 60 cell lines panel assay. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
318“…The National Cancer Institute (NCI) and the National Institutes of Health (NIH) Office of Disease Prevention held a workshop titled, “Extending Methods in Dietary Patterns Research”, in May of 2016. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
319por Moreno, Leydi M., Quiroga, Jairo, Abonia, Rodrigo, Ramírez-Prada, Jonathan, Insuasty, Braulio“…Seventeen of the synthesized compounds were selected and tested by the US National Cancer Institute (NCI) for their anticancer activity against 58 different human tumor cell lines. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
320“…To stimulate additional progress in this field, the two-day International Workshop on Structure and Function of the Lentiviral gp41 Cytoplasmic Tail, co-organized by Eric Freed and James Hoxie, was held at the National Cancer Institute in Frederick, MD (26–27 April 2018). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto